These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1329293)

  • 1. Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception?
    Mulder GJ
    Trends Pharmacol Sci; 1992 Aug; 13(8):302-4. PubMed ID: 1329293
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine-6-glucuronide, a potent mu agonist.
    Pasternak GW; Bodnar RJ; Clark JA; Inturrisi CE
    Life Sci; 1987 Dec; 41(26):2845-9. PubMed ID: 2826951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and Pharmacological Characterization of Permanently Charged Opioids.
    Mazak K; Noszal B; Hosztafi S
    Curr Med Chem; 2017; 24(33):3633-3648. PubMed ID: 28685673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of an opioid receptor probe: mode of binding of S-activated (-)-6 beta-sulfhydryldihydromorphine with the SH group in the mu-opioid receptor.
    Kanematsu K; Naito R; Shimohigashi Y; Ohno M; Ogasawara T; Kurono M; Yagi K
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1438-40. PubMed ID: 1975519
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum.
    Christensen CB; Mørk A; Geisler A
    Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors.
    Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J
    Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites.
    Bartlett SE; Dodd PR; Smith MT
    Pharmacol Toxicol; 1994 Aug; 75(2):73-81. PubMed ID: 7971741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-6-glucuronide has high affinity for the opioid receptor.
    Christensen CB; Jørgensen LN
    Pharmacol Toxicol; 1987 Jan; 60(1):75-6. PubMed ID: 3031640
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.
    Wentland MP; Lou R; Dehnhardt CM; Duan W; Cohen DJ; Bidlack JM
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1717-21. PubMed ID: 11425545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-6-glucuronide: actions and mechanisms.
    Kilpatrick GJ; Smith TW
    Med Res Rev; 2005 Sep; 25(5):521-44. PubMed ID: 15952175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide.
    MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1583-6. PubMed ID: 15745801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opium alkaloids and affinity labels.
    Archer S; Bidlack J; Mulholland GK
    NIDA Res Monogr; 1990; 96():21-34. PubMed ID: 2172823
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-6-glucuronide: receptor binding profile in bovine caudate nucleus.
    Christensen CB; Reiff L
    Pharmacol Toxicol; 1991 Feb; 68(2):151-3. PubMed ID: 1649469
    [No Abstract]   [Full Text] [Related]  

  • 17. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.
    Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW
    Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ligand recognition in the opioid receptors by modeling methods and the design of opioids].
    Kanematsu K
    Yakugaku Zasshi; 1998 Jan; 118(1):1-18. PubMed ID: 9484038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.